Shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) have been assigned a consensus rating of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 […]
Globus Medical, Inc. (NYSE:GMED – Get Rating) has been assigned an average recommendation of “Buy” from the fourteen research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among […]
Globus Medical (NYSE:GMED – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.100-$2.100 for the period, compared to the Thomson Reuters consensus estimate of $2.100. The company issued revenue guidance of $1.03 billion-$1.03 billion, compared to the consensus revenue estimate […]